Recent progress on genetics of optic neuritis

Chinese Journal of Ophthalmology

Volumn 47, Issue 12, 2011, Pages 1143-1146

  Zhao, Yan Yan ^a   Wei, Shi Hui ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Demyelinating diseases; Genetic predisposition to disease; Optic neuritis

Indexed keywords

DEMYELINATING DISEASE; GENETIC PREDISPOSITION; GENETICS; HUMAN; OPTIC NEURITIS; REVIEW;

DEMYELINATING DISEASES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; OPTIC NEURITIS;

EID: 84864384319     PISSN: 04124081     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0412-4081.2011.12.024     Document Type: Review

References (40)

1. Optic Neuritis study Group. The 5 year risk of MS after optic neuritis experience of the optic neuritis treatment trial. Neurology, 1997, 49:1404-1413.
2. 2006, 11: 367-369.
3. Bhatti M T, Schmitt N J, Beatty R L. Acute inflammatory demyelinating optic neuritis: current concepts in diagnosis and management. Optometry, 2005, 76: 526-535.
4. 2003, 13:165.
5. Begovich A B, Oksenberg J R. Variation in genes regulation the immune system and relationship to disease. Oxford: Taylor and Francis, 2000:139-174.
6. Kelly M A, Cavan D A, Penny M A, et al. The influence of HLA-DR and-DQ alleles on progression to multiple sclerosis following a clinically isolated syndrome. Hum Immunol, 1993, 37:185-191.
7. Söderström M, Lindqvist M, Hillert J, et al. Optic neuritis: findings on MRI, CSF examination and HLA class II typing in 60 patients and results of a short-term follow-up. J Neurol, 1994, 241: 391-397.
8. Hillert J, Käll T, Olerup O, et al. Distribution of HLA-Dw2 in optic neuritis and multiple sclerosis indicates heterogeneity. Acta Neurol Scand, 1996, 94: 161-166.
9. Frederiksen J L, Olesen J, Larsson H B, et al. Acute unilateral papillitis versus retro bulbar neuritis: relation to multiple sclerosis. Mult Scler, 1996, 1: 223-227.
10. Frederiksen J L, Madsen H O, Ryder L P, et al. HLA typing in acute optic neuritis. Relation to multiple sclerosis and magnetic resonance imaging findings. Arch Neurol, 1997, 54:76-80.
11. Söderström M, Ya-Ping J, Hillert J, et al. Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings. Neurology, 1998, 50:708-714.
12. Boiko A N, Guseva M E, Guseva M R, et al. Clinico- immunogenetic characteristics of multiple sclerosis with optic neuritis in children. J Neurovirol, 2000, 6(Suppl 2): S152-155.
13. Hauser S L, Oksenberg J R, Lincoln R, et al. Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS. Optic Neuritis Study Group. Neurology, 2000, 54: 1859-1861.
14. Barcellos L F, Oksenberg J R, Green A J, et al. Genetic basis for clinical expression in multiple sclerosis. Brain, 2002, 125: 150-158.
15. Kheradvar A, Tabassi A R, Nikbin B, et al. Influence of HLA on progression of optic neuritis to multiple sclerosis: results of a four-year follow-up study. Mult Scler, 2004, 10:526-631.
16. Amirzargar A A, Tabasi A, Khosravi F, et al. Optic neuritis, multiple sclerosis and human leukocyte antigen: results of a 4-year follow-up study. Neurol, 2005, 12: 25-30.
17. 2006, 42:501-506.
18. Wallace D C, Singh G, Loot M T, et al. Mitochondrial DNA mutation associated with Leber's Hereditary optic neuropathy. Science, 1988, 242:1427-1430.
19. Pilz D, Quarrell O W, Jones E W. Mitochondrial mutation commonly associated with Leber's hereditary optic neuropathy observed in patient with Wolfram syndrome. J Med Genet, 1994, 31:328.
20. Mayr-Wohlfart U, Paulus C, Henneberg A, et al. Mitochondrial DNA mutations in multiple sclerosis patients with severe optic involvement. Acta Neurol Scand, 1996, 94: 167-171.
21. Mojon D S, Fujihara K, Hirano M, et al. Leber's hereditary optic neuropathy mitochondrial DNA mutations in familial multiple sclerosis. Graefes Arch Clin Exp Ophthalmol, 1999, 237:348-350.
22. Reyruer P, Penisson B I, Moreau C, et al. mtDNA haplotype J: A contrubuting factor of optic neuritis. Eur J Hum Genet, 1999, 7: 404.
23. 2000, 26: 308-309.
24. Jia X, Xiao X, Guo X, et al. Screening for mt-DNA mutations in optic neuritis of unknown cause. Chin Med J (Engl), 2000, 113: 640-642.
25. 2002, 20:237-238.
26. Fugger L, Morling N, Sandberg-Wollheim M, et al. Tumor necrosis factor alpha gene polymer- phism in multiple sclerosis and optic neuritis. J Neuroimmunol, 1990, 27:85-88.
27. He B, Navikas V, Lundahl J, et al. Tumor necrosis factor alpha- 308 alleles in multiple sclerosis and optic neuritis. J Neuroimmunol, 1995, 63:143-147.
28. Pericak Vance M A, Rimmler J B, Martin E R, et al. Linkage and association analysis of chromosome 19q13 in multiple sclerosis. Neurogenetics, 2001, 3: 195-201.
29. Fazekas F, Strasser-Fuchs S, Kollegger H, et al. Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis. Neurology, 2001, 57:853-857.
30. Pinholt M, Frederiksen J L, Andersen P S, et al. Apo E in multiple sclerosis and optic neuritis: the apo E-epsilon4 allele is associated with progression of multiple sclerosis. Mult Scler, 2005, 11: 511-515.
31. Boylan K B, Takahashi N, Diamond M, et al. DNA length polymorphism located 5' to the human myelin basic protein gene. Am J Hum Genet, 1987, 40: 387-400.
32. Epplen C, Santos E, Dsouza M, et al. Genetic predisposition to multiple sclerosis as revealed by immunoprinting. Ann Neurol, 1997, 41:341-352.
33. He B, Yang B, Lundahl J, et al. The myelin basic protin gene in multiple sclerosis identification of discrete alleles of a 1.3kb tetranucleotide repeat sequence. Acta Neurol Scand, 1998, 97: 46-51.
34. Sellebjerg F, Frederiksen J L, Olsson T, et al. Peptide specificity of anti-myelin basic protein antibodies in patients with acute optic neuritis and the HLA system. Scand J Immunol, 1994, 39: 575-580.
35. Sellebjerg F, Madsen H O, Frederiksen J L, et al. Acute optic neuritis: myelin basic protein and proteolipid protein antibodies, affinity, and the HLA system. Ann Neurol, 1995, 38: 943-950.
36. Vella A, Cooper J D, Lowe C E, et al. Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am J Hum Genet, 2005, 76:773-779.
37. Brand O J, Lowe C E, Heward J M, et al. Association of the interleukin-2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs. Clin Endocrinol (Oxf), 2007, 66:508-512.
38. Hafler D A, Compston A, Sawcer S, et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med, 2007, 357:851-862.
39. Gregory S G, Schmidt S, Seth P, et al. Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet, 2007, 39:1083-1091.
40. Lundmark F, Duvefelt K, Iacobaeus E, et al. Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat Genet, 2007, 39:1108-1113.